Octagon Capital Advisors

Hedge fund · New York, New York

Octagon Capital Advisors is a hedge fund based in New York, New York. 182856-52P 7 portfolio companies are on record.

AUM
$985.3M
Portfolio companies
7
Recorded deals
—
Last investment
—

Octagon Capital Advisors key facts

  • Octagon Capital Advisors is a hedge fund based in New York, New York with 7 tracked portfolio companies.
  • Notable positions include AbogenBio, Bluejay Therapeutics, Alebund Pharmaceuticals.
  • The team roster lists 2 people.
  • Octagon Capital Advisors reports $985.3M in regulatory assets under management across 4 private funds, per its SEC Form ADV (2026-03).

About Octagon Capital Advisors

182856-52P

Investment focus

Its SEC Form ADV lists $985 million in regulatory assets under management across 4 private funds (Mar 2026).

Octagon Capital Advisors portfolio at a glance

7 portfolio companies are on record for Octagon Capital Advisors, including AbogenBio, Bluejay Therapeutics and Alebund Pharmaceuticals.

5 of the 7 carry a recorded valuation.

Octagon Capital Advisors team

2 people are on record at Octagon Capital Advisors. Senior names include Justin Hirsch (Chief Financial Officer) and Ting Jia (Founder). 2 of them have a verified direct contact on file.

Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.

Octagon Capital Advisors at the SEC

Form ADV · 2026-03 · CRD 306424
Regulatory AUM
$985.3M
Private fund assets
$1.2B
Private funds
4 · 3 private equity, 1 hedge
Staff
10
Registered office
NEW YORK, NY
SEC status
Approved

Reports custody of client assets.

Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as OCTAGON CAPITAL ADVISORS LP).

Free account
See more of the book
  • ·The top 10 names in the book — of 7 recorded positions
  • ·Watchlist + alerts for Octagon Capital Advisors's activity
Create free account

Membership and data by Private Market View

No card required

Portfolio

7 companies · priced for members
CompanyValuationRole
AbogenBio▮▮
Bluejay Therapeutics▮▮
Alebund Pharmaceuticals▮▮
+ 4 more companies · all 7, priced and dated
or a free account shows the top 10 names — no card
The whole book · Pro $99 a month

Membership and data by Private Market View

Team
2 people on record — 2 with verified contacts

Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.

See the team →

Frequently asked about Octagon Capital Advisors

What companies does Octagon Capital Advisors invest in?
Octagon Capital Advisors has 7 recorded portfolio companies, including AbogenBio, Bluejay Therapeutics, Alebund Pharmaceuticals.
What is Octagon Capital Advisors's AUM?
Octagon Capital Advisors manages approximately $985.3M in assets.